Hasna Bouchaab

1.2k total citations
43 papers, 530 citations indexed

About

Hasna Bouchaab is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Hasna Bouchaab has authored 43 papers receiving a total of 530 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 23 papers in Oncology and 8 papers in Surgery. Recurrent topics in Hasna Bouchaab's work include Lung Cancer Diagnosis and Treatment (13 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Lung Cancer Treatments and Mutations (7 papers). Hasna Bouchaab is often cited by papers focused on Lung Cancer Diagnosis and Treatment (13 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Lung Cancer Treatments and Mutations (7 papers). Hasna Bouchaab collaborates with scholars based in Switzerland, France and United States. Hasna Bouchaab's co-authors include Solange Peters, Tu Nguyen‐Ngoc, Alex A. Adjei, Michel Obéid, Craig Fenwick, Alfredo Addeo, Jean Bourhis, Enriqueta Felip, Antonio Passaro and Rafał Dziadziuszko and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and British Journal of Cancer.

In The Last Decade

Hasna Bouchaab

41 papers receiving 525 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hasna Bouchaab Switzerland	12	299	217	78	77	61	43	530
Andriani Charpidou Greece	16	310 1.0×	277 1.3×	64 0.8×	123 1.6×	42 0.7×	70	701
Nikhil Yegya‐Raman United States	12	147 0.5×	178 0.8×	66 0.8×	46 0.6×	107 1.8×	52	432
Ian A. Strohbehn United States	12	325 1.1×	173 0.8×	67 0.9×	47 0.6×	38 0.6×	28	592
Laura Ferrari Italy	11	307 1.0×	125 0.6×	157 2.0×	83 1.1×	48 0.8×	26	669
Wen‐Yen Chiou Taiwan	16	156 0.5×	158 0.7×	126 1.6×	123 1.6×	59 1.0×	60	667
Jacqueline Weinberg United States	6	267 0.9×	198 0.9×	32 0.4×	56 0.7×	33 0.5×	14	454
National Health Commission of PRC	11	180 0.6×	197 0.9×	127 1.6×	81 1.1×	40 0.7×	12	457
S. Friard France	13	254 0.8×	300 1.4×	62 0.8×	83 1.1×	19 0.3×	38	492
Engels Chou United States	7	197 0.7×	270 1.2×	84 1.1×	104 1.4×	41 0.7×	10	571
Taher Abu Hejleh United States	11	254 0.8×	158 0.7×	68 0.9×	121 1.6×	44 0.7×	45	445

Countries citing papers authored by Hasna Bouchaab

Since Specialization

Citations

This map shows the geographic impact of Hasna Bouchaab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hasna Bouchaab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hasna Bouchaab more than expected).

Fields of papers citing papers by Hasna Bouchaab

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hasna Bouchaab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hasna Bouchaab. The network helps show where Hasna Bouchaab may publish in the future.

Co-authorship network of co-authors of Hasna Bouchaab

This figure shows the co-authorship network connecting the top 25 collaborators of Hasna Bouchaab. A scholar is included among the top collaborators of Hasna Bouchaab based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hasna Bouchaab. Hasna Bouchaab is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Imbimbo, Martina, Maxime Borgeaud, Margaret Ottaviano, et al.. (2025). Thymic epithelial tumors: what’s new and what’s next?. 4. 100024–100024. 1 indexed citations

Locatelli, Isabella, Khalil Zaman, Antonia Digklia, et al.. (2024). A pharmacist-led interprofessional medication adherence program improved adherence to oral anticancer therapies: The OpTAT randomized controlled trial. PLoS ONE. 19(6). e0304573–e0304573. 3 indexed citations

Dowlati, Afshin, Horst-Dieter Hummel, Stéphane Champiat, et al.. (2024). Sustained Clinical Benefit and Intracranial Activity of Tarlatamab in Previously Treated Small Cell Lung Cancer: DeLLphi-300 Trial Update. Journal of Clinical Oncology. 42(29). 3392–3399. 22 indexed citations

Abdelnour‐Berchtold, Etienne, Michel González, Thorsten Krueger, et al.. (2024). Phase I clinical trial testing the dose escalation and expansion of Pressurized IntraThoracic Hyperthermic Aerosol Cisplatin administration (PITHAC) for the management of pleural carcinosis. Cancer Treatment and Research Communications. 42. 100858–100858.

Berezowska, Sabina, et al.. (2024). Pathology of Surgically Resected Lung Cancers Following Neoadjuvant Therapy. Advances in Anatomic Pathology. 31(5). 324–332. 1 indexed citations

Obéid, Michel, Victor Joo, Douglas Daoudlarian, et al.. (2024). High-dimensional longitudinal immune profiling uncovers a dual role of the CXCL9/CXCR3, CXCL13/CXCR5, and CCL11/CCL3 axis in the coupling of immune-related adverse events to immune checkpoint inhibitor response.. Journal of Clinical Oncology. 42(16_suppl). 2512–2512. 1 indexed citations

Durham, André, Hasna Bouchaab, Alban Lovis, et al.. (2022). Lung stereotactic radiation therapy: Intercomparison of irradiation devices in terms of outcome and predictive factors. Cancer/Radiothérapie. 27(1). 31–41. 2 indexed citations

Boughdad, Sarah, Sofiya Latifyan, Craig Fenwick, et al.. (2021). ⁶⁸Ga-DOTATOC PET/CT to detect immune checkpoint inhibitor-related myocarditis. Journal for ImmunoTherapy of Cancer. 9(10). e003594–e003594. 49 indexed citations

Perentes, Jean Yannis, Etienne Abdelnour‐Berchtold, Matthieu Zellweger, et al.. (2021). Impact of an enhanced recovery after surgery pathway on thoracoscopic lobectomy outcomes in non-small cell lung cancer patients: a propensity score-matched study. Translational Lung Cancer Research. 10(1). 93–103. 24 indexed citations

10.

Lovis, Alban, et al.. (2021). Is sleeve lobectomy safe after induction therapy?—a systematic review and meta-analysis. Journal of Thoracic Disease. 13(10). 5887–5898. 4 indexed citations

11.

Pozzessere, Chiara, Hasna Bouchaab, Igor Letovanec, et al.. (2020). Relationship between pneumonitis induced by immune checkpoint inhibitors and the underlying parenchymal status: a retrospective study. ERJ Open Research. 6(1). 165–2019. 24 indexed citations

12.

Passaro, Antonio, Alfredo Addeo, Christophe von Garnier, et al.. (2020). ESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancer. ESMO Open. 5(Suppl 3). e000820–e000820. 91 indexed citations

13.

Schmid, Sabine, Laetitia Mauti, Alex Friedlaender, et al.. (2020). Outcomes with immune checkpoint inhibitors for relapsed small-cell lung cancer in a Swiss cohort. Cancer Immunology Immunotherapy. 69(8). 1605–1613. 6 indexed citations

14.

Girard, Nicolas, Rainer Fietkau, Marina Chiara Garassino, et al.. (2020). 1242P Characteristics of the first 615 patients enrolled in Pacific R: A study of the first real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy. Annals of Oncology. 31. S805–S806. 2 indexed citations

15.

Curioni‐Fontecedro, Alessandra, Jean Yannis Perentes, Hans Gelpke, et al.. (2019). Preoperative chemotherapy and radiotherapy concomitant to cetuximab in resectable stage IIIB NSCLC: a multicentre phase 2 trial (SAKK 16/08). British Journal of Cancer. 120(10). 968–974. 5 indexed citations

16.

Scher, Nathaniel, Marie‐Catherine Vozenin, Hasna Bouchaab, Mahmut Özsahin, & Jean Bourhis. (2019). Isodose 20 Gy found as a threshold dose for radiation recall dermatitis. Clinical and Translational Radiation Oncology. 17. 14–16. 3 indexed citations

17.

Pruvot, Étienne, Juerg Schwitter, Véronique Vallet, et al.. (2019). Curative management of a cardiac metastasis from lung cancer revealed by an electrical storm. Clinical and Translational Radiation Oncology. 21. 62–65. 8 indexed citations

18.

Castelli, J., Adrien Depeursinge, John O. Prior, et al.. (2017). A PET-based nomogram for oropharyngeal cancers. European Journal of Cancer. 75. 222–230. 13 indexed citations

19.

Bouchaab, Hasna, et al.. (2015). Stereotactic body radiotherapy with helical TomoTherapy for medically inoperable early stage primary and second-primary non-small-cell lung neoplasm: 1-year outcome and toxicity analysis. British Journal of Radiology. 88(1049). 20140687–20140687. 8 indexed citations

20.

Peters, Solange, Hasna Bouchaab, Olivier Gaide, et al.. (2014). Dramatic response of vemurafenib-induced cutaneous lesions upon switch to dual BRAF/MEK inhibition in a metastatic melanoma patient. Melanoma Research. 24(5). 496–500. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact